Pharmaceutical Treatment Bimatoprost Powder Bimatoprost

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-Sung Bimatoprost
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Bimatoprost
• Name: Bimatoprost Powder
• Assay: HPLC 99%
• Appearance: White Powder
• Color: White
• CAS No .: 155206-00-1
• Mf: C25h37no4
• MW: 415.574
• Melting Point: 66-68
• Boiling Point: 629.8
• Density: 1.145
• Test Method: HPLC
• Grade: Pharmaceutical Grade
• Application: Pharmaceutical
• Specific: COA
• Transport Package: Negotiabie
• Specification: 99%
• Trademark: D-Sung
• Origin: Xi′an Shaanxi
• Production Capacity: 500kg/Month

Product Description

Pharmaceutical Treatment Bimatoprost Powder Bimatoprost

Product Description

Product Details

Product Name	Bimatoprost
Appearance	White Powder
CAS NO .	155206-00-1
MF	C25h37no4
MW	415.574

Bimatoprost is a prostaglandin drug that was first used to treat eye diseases such as glaucoma. The drug name is Lumigan. However, during the treatment process, the patient unexpectedly discovered a significant increase in the diameter, length, and density of their eyelashes. Afterwards, bimatoprost was used in clinical trials for eyelash beauty, with its enormous effect on thickening and thickening eyelashes

Application&Function

Bimatoprost is a synthesized F2 α derivative of prostamide, which can selectively simulate the action of prostaamine produced in the body, increase the rate of aqueous humor production, reduce the resistance of aqueous humor outflow, and lower intraocular pressure (IOP) by increasing the outflow of aqueous humor from the trabecular meshwork channel and uveoscleral channel. It is considered to be the strongest local anti glaucoma drug in reducing intraocular pressure at present Suitable for the treatment of open-angle glaucoma (POAG) or high intraocular pressure (OHT) patients who have failed to respond to other intraocular pressure lowering drugs.

Specification